Use of donor T-lymphocytes expressing herpes-simplex thymidine kinase in allogeneic bone marrow transplantation: a phase I-II study.
Tiberghien
P
P
Laboratoire d'Histocompatibilité et Thérapeutique Immuno-Moléculaire Etablissement de Transfusion Sanguine de Franche-Comté, Besançon. pierre.tiberghien@univ-fcomte.fr
Cahn
J Y
JY
Brion
A
A
Deconinck
E
E
Racadot
E
E
Hervé
P
P
Milpied
N
N
Lioure
B
B
Gluckman
E
E
Bordigoni
P
P
Jacob
W
W
Chiang
Y
Y
Marcus
S
S
Reynolds
C
C
Longo
D
D
D016026:Bone Marrow Transplantation / Q000276:immunology; D002985:Clinical Protocols; D017321:Clinical Trials, Phase I as Topic / Q000379:methods*; D017322:Clinical Trials, Phase II as Topic / Q000379:methods*; D018014:Gene Transfer Techniques; D015316:Genetic Therapy; D005822:Genetic Vectors; D006086:Graft vs Host Disease / Q000276:immunology / Q000517:prevention & control / Q000628:therapy*; D006801:Humans; D012190:Retroviridae / Q000235:genetics*; D018139:Simplexvirus / Q000201:enzymology*; D013601:T-Lymphocytes / Q000201:enzymology* / Q000637:transplantation; D013937:Thymidine Kinase / Q000235:genetics*; D016896:Treatment Outcome
D013937:Thymidine Kinase